Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.
Alzforum,
Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, Stomrud E, Lee J, Fitz L, Samad TA, Ramaswamy G…
Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, Stomrud E, Lee J, Fitz L, Samad TA, Ramaswamy G…
To date, the development of disease-modifying therapies for Alzheimer’s disease (AD) has largely focused on the removal of…